High concentrations of Tregs-associated markers, such as CTLA-4, glucocorticoid-induced tumor necrosis factor receptor (GITR) and OX40 are reported in peripheral blood of MM patients, and this might enhance their suppressive function [83]. This evidence concerns the gene CTLA4 and Miyoshi myopathy.